EMD-52409
Outward-open structure of human glycine transporter 2 bound to allosteric inhibitor ORG25543
EMD-52409
Single-particle2.49 Å
Deposition: 22/12/2024Map released: 25/02/2026
Last modified: 25/03/2026
Sample Organism:
Homo sapiens
Sample: Human glycine transporter GlyT2 bound to allosteric inhibitor ORG25543
Fitted models: 9hue
Deposition Authors: Cantwell Chater RP
,
Peiser-Oliver J
,
Pati TK
,
Quinn AS,
Lotsaris I
,
Frangos ZJ
,
Anderson KE,
Tischer AE
,
Williams-Noonan BJ
,
Aubrey KR,
O Mara ML,
Michaelides M
,
Mohammadi SA
,
Cioffi CL
,
Vandenberg RJ
,
Shahsavar A
Sample: Human glycine transporter GlyT2 bound to allosteric inhibitor ORG25543
Fitted models: 9hue
Deposition Authors: Cantwell Chater RP
,
Peiser-Oliver J
,
Pati TK
,
Quinn AS,
Lotsaris I
,
Frangos ZJ
,
Anderson KE,
Tischer AE
,
Williams-Noonan BJ
,
Aubrey KR,
O Mara ML,
Michaelides M
,
Mohammadi SA
,
Cioffi CL
,
Vandenberg RJ
,
Shahsavar A
A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects.
Cantwell Chater RP
,
Peiser-Oliver J
,
Pati TK
,
Quinn AS,
Lotsaris I
,
Frangos ZJ
,
Anderson KE,
Tischer AE
,
Williams-Noonan BJ
,
Aubrey KR,
O'Mara ML
,
Michaelides M
,
Mohammadi SA
,
Cioffi CL
,
Vandenberg RJ
,
Shahsavar A
(2025) bioRxiv
,
Peiser-Oliver J
,
Pati TK
,
Quinn AS,
Lotsaris I
,
Frangos ZJ
,
Anderson KE,
Tischer AE
,
Williams-Noonan BJ
,
Aubrey KR,
O'Mara ML
,
Michaelides M
,
Mohammadi SA
,
Cioffi CL
,
Vandenberg RJ
,
Shahsavar A
(2025) bioRxiv
Grant Support:
- Lundbeckfonden: R368-2021-522 (Denmark)
- Novo Nordisk Foundation: NNF23OC0087107 (Denmark)
- National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA): R01DA048879 (United States)
